Charles River Laboratories International Inc (CRL)

07:24 AM

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN

07:24 AM

12:00 PM

Charles River Laboratories targets $9.10-$9.60 EPS in 2025 amid cost optimization efforts - MSN

12:00 PM

Feb 21, 2025

William Blair cuts Charles River Labs stock rating to Market Perform - MSN

Feb 21, 2025

Feb 21, 2025

Charles River Executives Buy Company Stock Amidst Plan Terminations - Investing.com

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories executive buys $249k in common stock - Investing.com India

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories executive sells shares worth $715,000 - Investing.com

Feb 21, 2025

Feb 21, 2025

Recent Transactions by Executives at Charles River Laboratories - TradingView

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories International (NYSE:CRL) Price Target Cut to $173.00 by Analysts at Robert W. Baird - MarketBeat

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Feb 21, 2025

Feb 21, 2025

Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace

Feb 21, 2025

Feb 21, 2025

New York State Teachers Retirement System Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Feb 21, 2025

Feb 21, 2025

Empower Advisory Group LLC Acquires 6,747 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Feb 21, 2025

Feb 21, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Down 7.4% in January - MarketBeat

Feb 21, 2025

Feb 21, 2025

Vontobel Holding Ltd. Acquires Shares of 1,817 Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Feb 21, 2025

Feb 20, 2025

Charles River Laboratories International (NYSE:CRL) Issues FY25 Earnings Guidance - MarketBeat

Feb 20, 2025

Feb 20, 2025

Stephens Cuts Charles River Laboratories International Price Target to $190 From $240 - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Charles River Labs makes good on promise to reduce headcount - The Business Journals

Feb 20, 2025

Feb 20, 2025

Charles River Laboratories International (NYSE:CRL) Shares Gap Up on Earnings Beat - MarketBeat

Feb 20, 2025

Feb 20, 2025

Charles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat

Feb 20, 2025

Feb 20, 2025

Charles River Laboratories International (NYSE:CRL) Issues FY 2025 Earnings Guidance - MarketBeat

Feb 20, 2025

Feb 20, 2025

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $210 From $215, Maintains Buy Rating - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

JPMorgan Adjusts Price Target on Charles River Laboratories International to $165 From $175, Maintains Neutral Rating - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Bryn Mawr Capital Management LLC Acquires 33,850 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Feb 20, 2025

Feb 20, 2025

Charles River: Q4 Earnings Snapshot - The Pioneer

Feb 20, 2025

Feb 20, 2025

Charles River Laboratories International Inc (CRL) Q4 2024 Earni - GuruFocus.com

Feb 20, 2025

Feb 20, 2025

Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Charles River Laboratories Reports 2024 Earnings and 2025 Outlook - TipRanks

Feb 19, 2025

Feb 19, 2025

Charles River Labs stock target cut to $175 by Evercore ISI - Investing.com South Africa

Feb 19, 2025

Feb 19, 2025

CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall - MSN

Feb 19, 2025

Feb 19, 2025

Charles River Labs Investor Failed to Depict Fraud, Company Says - Bloomberg Law

Feb 19, 2025

Feb 19, 2025

Narrow-Moat Charles River Faces Macroeconomic Pressures in Near Term; Positive Long-Term Outlook - Morningstar

Feb 19, 2025

Feb 19, 2025

Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance - Benzinga

Feb 19, 2025

Feb 19, 2025

Q4 Earnings Surpass Expectations For The Andersons And Charles River Laboratories - Evrim Ağacı

Feb 19, 2025

Feb 19, 2025

Charles River Labs diversifies monkey business in face of political headwinds - The Business Journals

Feb 19, 2025

Feb 19, 2025

In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.

Feb 19, 2025

Feb 19, 2025

Evercore ISI Adjusts Charles River Laboratories International Price Target to $175 From $195, Maintains In Line Rating - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Earnings call transcript: Charles River Labs Q4 2024 beats EPS forecast - Investing.com

Feb 19, 2025

Feb 19, 2025

Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories International (NYSE:CRL) Price Target Lowered to $166.00 at Barclays - MarketBeat

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4 By Stock Story - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories International, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 28, 2024 - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories Exceeds Q4 Expectations with $1.00 Billion Revenue and $2.66 Non-GAAP EPS - GuruFocus.com

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by J.P. Marvel Investment Advisors LLC - MarketBeat

Feb 19, 2025

Feb 19, 2025

Charles River beats quarterly estimates on stable demand for drug development services - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories reports Q4 earnings beat, shares edge up By Investing.com - Investing.com Nigeria

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories reports Q4 earnings beat, shares edge up - Investing.com

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories Q4 24 Earnings Conference Call At 8:30 AM ET - Nasdaq

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories Q4 Higher Earnings Higher, Revenue Lower; 2025 Guidance Issued - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

CHARLES RIVER LABS INTL Earnings Results: $CRL Reports Quarterly Earnings - Nasdaq

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories Reports Q4 and Full-Year 2024 Results - TradingView

Feb 19, 2025

Feb 19, 2025

CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 19, 2025

Feb 19, 2025

Charles River Laboratories earnings beat by $0.12, revenue topped estimates - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

Earnings Flash (CRL) Charles River Laboratories International Reports Q4 Adjusted EPS $2.66, vs. FactSet Est of $2.53 - Marketscreener.com

Feb 19, 2025